Filing Details
- Accession Number:
- 0001447362-20-000207
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-09 16:03:12
- Reporting Period:
- 2020-09-04
- Accepted Time:
- 2020-09-09 16:03:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1447362 | Castle Biosciences Inc | CSTL | Services-Medical Laboratories (8071) | 770701774 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1782994 | E. Bernhard Spiess | C/O Castle Biosciences, Inc. 820 S. Friendswood Drive, Ste. 201 Friendswood TX 77546 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-09-04 | 20,000 | $47.00 | 86,747 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-04 | 5,112 | $49.00 | 81,635 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-08 | 14,888 | $49.00 | 66,747 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 18, 2020.
- Includes 1,121 shares acquired under the Issuer's employee stock purchase plan on August 31, 2020.